METHODS AND SYSTEMS FOR INTRAVENTRICULAR BRAIN STIMULATION

• US 20150011927A1
• Filed: 04/30/2014
• Published: 01/08/2015
• Est. Priority Date: 05/01/2013
• Status: Active Grant

• Current Assignee: Sherwin Hua
• Original Assignee: Sherwin Hua
• Inventors: Hua, Sherwin
• Granted Patent: US 9,919,146 B2
• Time in Patent Office: Days
• US Class Current: 604/9
• CPC Class Codes: A61N 1/0529 Electrodes for brain stimulation
• CPC Class Codes: A61N 1/0534 Electrodes for deep brain stimulation
• CPC Class Codes: A61N 1/36064 Epilepsy
• CPC Class Codes: A61N 1/36067 Movement disorders, e.g. tremor or Parkinson disease stimulating motor muscle A61N1/36003
• CPC Class Codes: A61N 1/36082 Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease

Abstract

The present application is directed to devices and methods that can treat dementia or other brain disorders via electrical stimulation. Embodiments disclosed herein utilize brain stimulation of brain areas involved in memory and cognition through an intraventricular approach. Brain stimulation is combined with CSF flow in an intraventricular electrode having one or more passageways to permit fluid to flow therethrough. For example, an intraventricular electrode shunt catheter can be safely placed in any part of the ventricular system and through any foramen or aqueduct of the ventricular system without fear of obstruction to CSF flow.

Claims

1. A neuromodulation system configured to pass into, within, or through a ventricle in the brain, the system comprising:

one or more passageways for fluid; and

an electrode or effector configured to modulate neural activity thereby modulating a neural state.

2. The neuromodulation system of claim 1, wherein the neural activity modulated comes from one of more of the following:

brain cells, neural fibers, fornix, thalamus, anterior nucleus of thalamus, a structure within the circuit of Papez, and hypothalamus.

3. The neuromodulation system of claim 1, wherein the neural state is one or more of the following neural states:

a normal neural state, an abnormal neural state, an abnormal neural state related to seizure, an abnormal neural state related to epilepsy, an abnormal neural state related to Alzheimer'"'"'s disease, an abnormal neural state related to Mild Cognitive Impairment, an abnormal neural state related to normal pressure hydrocephalus, an abnormal neural state related to Attention Deficit and Hyperactivity Disorder, an abnormal neural state related to encephalopathy, an abnormal neural state related to stroke, an abnormal neural state related to Parkinson'"'"'s Disease, an abnormal neural state related to neurodegenerative disease, an abnormal neural state related to cerebral palsy, an abnormal neural state related to schizophrenia, an abnormal neural state related to neuropsychiatric disorder.

4. The neuromodulation system of claim 1, wherein the modulation of neural activity comprises one or more of the following:

an increase in neural activity, a decrease in neural activity, a modulation of memory, attention, concentration.

5. The neuromodulation system of claim 1, wherein perforations in the passageway permit cerebral spinal fluid to flow therethrough.

6. The neuromodulation system of claim 1, wherein the passageway is configured to permit cerebrospinal fluid to flow out of the cranium to drain into a body cavity including the circulatory system, peritoneum, or pleural space, and wherein the passageway comprises a shunt system with a valve controlling cerebrospinal fluid flow.

7. The neuromodulation system of claim 1, wherein the passageway is configured so as to not be open to cerebrospinal fluid flow outside the cranium.

8. The neuromodulation system of claim 1, wherein the tip of the electrode or effector is curved to conform to the contour of the ventricular anatomy to reach the target neural structure

9. The neuromodulation system of claim 8, wherein the curved electrode or effector tip reaches both fornices by curving from one foramen of Monroe past the ipsilateral fornix to the contralateral fornix.

10. The neuromodulation system of claim 1, wherein the system is configured to allow the electrode or effector to reach both the fornix and anterior nucleus of thalamus.

11. The neuromodulation system of claim 1, the electrode or effector is carried by a catheter, and wherein the catheter uses mechanical properties to maintain contact with neural structures on the wall of the ventricle or foramen of Monroe

12. The neuromodulation system of claim 1, the electrode or effector is carried by a catheter, and wherein the catheter diameter can be enlarged or decreased to better fit within the ventricle or foramen of Monroe so that the electrode or effector is in better contact with the neural structures on the wall of the ventricular system.

13. The neuromodulation system of claim 1, wherein the electrode or effector is carried by a catheter, and wherein the catheter is inserted to the target using one or more of the following means:

stereotactic guidance, an endoscopic viewer, fluoroscopic visualization guided by radio-opaque substance, and ventriculography.

14. A brain stimulation method comprising using the system of any one of the preceding claims.

15. A neuromodulation system comprising:

one or more electrodes configured for intraventricular brain stimulation; and

means for allowing cerebral spinal fluid flow during intraventricular placement of the one or more electrodes.

16. The neuromodulation system of claim 15, wherein the means for allowing cerebral spinal fluid flow comprises a shunt catheter.

17. The neuromodulation system of claim 15, wherein the means for allowing cerebral spinal fluid flow comprises one or more passageways.

18. The neuromodulation system of claim 15, wherein the means for allowing cerebral spinal fluid flow comprises a Blake drain.

19. A method of modulating neural activity, the method comprising:

providing a shunt electrode comprising an electrode and a passageway for fluid flow through the shunt electrode;

inserting the shunt electrode into a brain;

modulating neural activity in the brain with the shunt electrode.

20. The method of claim 19, wherein the neural activity modulated comes from one of more of the following:

brain cells, neural fibers, fornix, thalamus, anterior nucleus of thalamus, a structure within the circuit of Papez, and hypothalamus.

21. The method of claim 19, wherein prior to the modulating, the neural activity is in one or more of the following neural states:

a normal neural state, an abnormal neural state, an abnormal neural state related to seizure, an abnormal neural state related to epilepsy, an abnormal neural state related to Alzheimer'"'"'s disease, an abnormal neural state related to Mild Cognitive Impairment, an abnormal neural state related to Attention Deficit and Hyperactivity Disorder, an abnormal neural state related to encephalopathy, an abnormal neural state related to stroke, an abnormal neural state related to Parkinson'"'"'s Disease, an abnormal neural state related to neurodegenerative disease, an abnormal neural state related to cerebral palsy, an abnormal neural state related to schizophrenia, an abnormal neural state related to neuropsychiatric disorder.

22. The method of claim 19, wherein the modulation of neural activity comprises one or more of the following:

an increase in neural activity, a decrease in neural activity, a modulation of memory, attention, or concentration.

23. The method of claim 19, wherein perforations in the passageway permit cerebral spinal fluid to flow therethrough.

24. The method of claim 19, wherein the passageway has perforations proximal to the electrode, distal to the electrode, or both proximal and distal to the electrode for cerebrospinal fluid flow between compartments proximal and distal to the electrode.

25. The method of claim 19, comprising inserting the shunt electrode through the foramen of Monroe.

26. The method of claim 19, wherein the passageway is configured to permit cerebrospinal fluid to flow out of the cranium to a reservoir.

27. The method of claim 19, wherein the passageway is configured to permit cerebrospinal fluid to flow out of the cranium to drain into a body cavity including the circulatory system, peritoneum, or pleural space and wherein the passageway comprises a shunt system with a valve controlling cerebrospinal fluid flow.

28. The method of claim 19, wherein the passageway is configured so as to not be open to cerebrospinal fluid flow outside the cranium.

29. The method of claim 19, wherein the tip of the shunt electrode is curved to conform to the contour of the ventricular anatomy to reach the target neural structure.

30. The method of claim 29, wherein the curved electrode or effector tip reaches both fornices by curving from one foramen of Monroe past the ipsilateral fornix to the contralateral fornix.

31. The method of claim 19, wherein the shunt electrode comprises a catheter, wherein the catheter uses mechanical properties to maintain contact with neural structures on the wall of the ventricle or foramen of Monroe.

32. The method of claim 19, wherein the shunt electrode comprises a catheter, and wherein the catheter diameter can be enlarged or decreased to better fit within the ventricle or foramen of Monroe so that the electrode or effector is in better contact with the neural structures on the wall of the ventricular system.

33. The method of claim 19, wherein the shunt electrode comprises a catheter, and wherein the shunt electrode is inserted into the target site in the brain using one or more of the following means:

stereotactic guidance, an endoscopic viewer, fluoroscopic visualization guided by radio-opaque substance, and ventriculography.